NCT06452329 2025-12-04
A Study to Evaluate Nivolumab in Patients With Unresectable Advanced/Metastatic Gastric Cancer and Gastroesophageal Junction Cancer
Bristol-Myers Squibb
Completed
Bristol-Myers Squibb
Jiangsu Cancer Institute & Hospital
Cancer Institute and Hospital, Chinese Academy of Medical Sciences